TY - JOUR
T1 - Simultaneous Prediction of Area Under the Curves of Mycophenolic Acid and Its Metabolites and Enterohepatic Recirculation in Kidney Transplant Recipients
AU - Mohamed, Moataz E
AU - Saqr, Abdelrahman
AU - Onyeaghala, Guillaume C
AU - Remmel, Rory P
AU - Staley, Christopher
AU - Dorr, Casey R.
AU - Teigen, Levi
AU - Guan, Weihua
AU - Madden, Henry
AU - Munoz, Julia
AU - Sanchez, Bryan
AU - Vo, Duy
AU - El-Rifai, Rasha
AU - Oetting, William S
AU - Matas, Arthur J
AU - Israni, Ajay K
AU - Jacobson, Pamala A.
N1 - Publisher Copyright:
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2025
Y1 - 2025
N2 - Background: Therapeutic drug monitoring of mycophenolic acid (MPA) is limited due to the requirement for intensive pharmacokinetic sampling to assess the area under the curve (AUC). Limited sampling strategies (LSS) offer a practical alternative; however, enterohepatic recirculation (EHR) affects prediction accuracy and precision. This study is the first to develop LSS models capable of simultaneously predicting the AUC of MPA, its metabolites [mycophenolic acid glucuronide (MPAG) and acyl mycophenolic acid glucuronide (Acyl-MPAG)], and MPA EHR in kidney transplant recipients (KTRs). Methods: Intensive pharmacokinetic sampling was conducted in 84 adult KTRs receiving mycophenolate mofetil. MPA AUC0-12 was calculated, and MPA EHR was determined. During the development of the LSS models, a balanced representation of patients with high and low EHR was ensured. Multiple linear regression was used to develop AUC prediction models for MPA, MPAG, and Acyl-MPAG, as well as an EHR prediction model. The best models were selected based on prediction performance, the highest prediction concordance, and the shortest interval between the first and last samples. Results: Three models for AUC0-12 prediction were identified, incorporating 4, 5, and 6 concentration timepoints. The LSS model with 6 concentrations demonstrated the best performance, with excellent prediction concordance (100% for MPA and MPAG, and 93% for Acyl-MPAG). The EHR prediction model included 4 concentrations and exhibited an;80% prediction concordance. An online calculator was developed for these models. Conclusions: The developed LSS models simultaneously predict MPA, MPAG, and Acyl-MPAG AUC0-12 using the same timepoints with high accuracy and precision. MPA EHR can be predicted using 4 concentration timepoints. The inclusion of late concentration timepoints is essential for the high predictive performance of LSS models.
AB - Background: Therapeutic drug monitoring of mycophenolic acid (MPA) is limited due to the requirement for intensive pharmacokinetic sampling to assess the area under the curve (AUC). Limited sampling strategies (LSS) offer a practical alternative; however, enterohepatic recirculation (EHR) affects prediction accuracy and precision. This study is the first to develop LSS models capable of simultaneously predicting the AUC of MPA, its metabolites [mycophenolic acid glucuronide (MPAG) and acyl mycophenolic acid glucuronide (Acyl-MPAG)], and MPA EHR in kidney transplant recipients (KTRs). Methods: Intensive pharmacokinetic sampling was conducted in 84 adult KTRs receiving mycophenolate mofetil. MPA AUC0-12 was calculated, and MPA EHR was determined. During the development of the LSS models, a balanced representation of patients with high and low EHR was ensured. Multiple linear regression was used to develop AUC prediction models for MPA, MPAG, and Acyl-MPAG, as well as an EHR prediction model. The best models were selected based on prediction performance, the highest prediction concordance, and the shortest interval between the first and last samples. Results: Three models for AUC0-12 prediction were identified, incorporating 4, 5, and 6 concentration timepoints. The LSS model with 6 concentrations demonstrated the best performance, with excellent prediction concordance (100% for MPA and MPAG, and 93% for Acyl-MPAG). The EHR prediction model included 4 concentrations and exhibited an;80% prediction concordance. An online calculator was developed for these models. Conclusions: The developed LSS models simultaneously predict MPA, MPAG, and Acyl-MPAG AUC0-12 using the same timepoints with high accuracy and precision. MPA EHR can be predicted using 4 concentration timepoints. The inclusion of late concentration timepoints is essential for the high predictive performance of LSS models.
KW - Acyl-MPAG
KW - kidney transplant
KW - limited sampling strategy
KW - MPAG
KW - mycophenolate mofetil
KW - mycophenolic acid
KW - therapeutic drug monitoring
UR - http://www.scopus.com/inward/record.url?scp=105005877384&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=105005877384&partnerID=8YFLogxK
U2 - 10.1097/ftd.0000000000001336
DO - 10.1097/ftd.0000000000001336
M3 - Article
C2 - 40315256
AN - SCOPUS:105005877384
SN - 0163-4356
JO - Therapeutic drug monitoring
JF - Therapeutic drug monitoring
M1 - 10.1097/FTD.0000000000001336
ER -